A safety trial of high dose glyceryl triacetate for Canavan disease.
Segel R, Anikster Y, Zevin S, Steinberg A, Gahl WA, Fisher D, Staretz-Chacham O, Zimran A, Altarescu G.
Segel R, et al. Among authors: zimran a.
Mol Genet Metab. 2011 Jul;103(3):203-6. doi: 10.1016/j.ymgme.2011.03.012. Epub 2011 Mar 15.
Mol Genet Metab. 2011.
PMID: 21474353
Clinical Trial.